改良无喇叭口短全覆膜金属支架治疗难治性良性胰管狭窄的初步研究
这项单臂前瞻性研究纳入25例慢性胰腺炎合并难治性主胰管狭窄患者,置入新型改良无喇叭口全覆膜自膨式金属支架,3个月后取出。所有患者支架置入技术成功,狭窄均获缓解,中位随访34个月仅2例因狭窄复发伴腹痛需再干预。
要点
- 支架相关不良事件少,仅1例发生支架移位,未见支架诱导的新发狭窄。
- 中位随访34个月,狭窄复发伴腹痛需再干预者占8.0%。
核心结论
- 内镜下置入新型改良无喇叭口全覆膜自膨式金属支架可实现难治性良性胰管狭窄的长期缓解并减轻疼痛,同时减少支架移位和支架诱导新发狭窄等不良事件。
研究设计与样本
- 单臂前瞻性研究,连续纳入25例有症状的慢性胰腺炎合并难治性主胰管狭窄患者,置入新型无喇叭口全覆膜自膨式金属支架,3个月后取出并长期随访。
主要发现
- 25例患者支架置入技术全部成功,14例(56.0%)行支架管内放置。
- 17例(68.0%)使用直径8 mm支架,22例(88.0%)和3例(12.0%)分别置入长度3 cm和5 cm支架。
- 1例(4.0%)发生支架移位,其余支架均成功取出。
- 支架取出后所有患者主胰管狭窄均获缓解,未观察到支架相关新发狭窄。
- 支架取出后中位随访34个月(四分位距25-56),2例(8.0%)因狭窄复发伴腹痛需再干预。
临床怎么用
- 对于慢性胰腺炎合并难治性主胰管狭窄,可考虑使用新型无喇叭口全覆膜金属支架,按狭窄位置和长度选择管内或经乳头放置,3个月后取出。
局限性
- 本研究为单臂设计,样本量25例,缺乏对照组,结论需更大队列或对照研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Fully covered self-expanding metal stents (FCSEMSs) are considered to be more effective than plastic stents for the treatment of main pancreatic duct (MPD) strictures associated with chronic pancreatitis (CP) because of their larger diameter and exertion of a radial expansion force. However, the current FCSEMSs have several limitations. To overcome these, a novel modified nonflared FCSEMS was developed. In this study we conducted a prospective long-term follow-up evaluation of the efficacy of the novel FCSEMS for the treatment of refractory benign PD strictures in patients with CP. METHODS: Consecutive patients with symptomatic CP associated with refractory MPD strictures were enrolled prospectively in this single-arm study. The nonflared FCSEMS was placed intraductally or transpapillary according to the location and length of the stricture. Stent removal was performed at 3 months after placement. The primary outcome was the resolution of the pancreatic ductal stricture. RESULTS: Endoscopic placement of modified nonflared FCSEMSs was technically successful in all 25 patients. Intraductal FCSEMS placement was performed in 14 patients (56.0%). Stents of diameter 8 mm were used in 17 patients (68.0%). Stents of lengths 3 and 5 cm were inserted in 22 (88.0%) and 3 (12.0%) patients, respectively. In 1 patient (4.0%), stent migration developed. All other stents were removed successfully. After stent removal, resolution of the MPD stricture was confirmed in all patients, and no FCSEMS-related de novo stricture was observed. During the follow-up period (median, 34 months; interquartile range, 25-56) after the stents had been removed from the 25 patients, reintervention for recurrence of MPD stricture with abdominal pain was performed in 2 patients (8.0%). CONCLUSIONS: Endoscopic placement of a novel modified nonflared FCSEMS resulted in long-term stricture resolution with pain relief and reduced the rate of stent-related adverse events, particularly stent migration and stent-induced de novo MPD stricture. (Clinical trial registration number: UMIN000035681.).
引用
- Lee YN, Moon JH, Park JK, et al. Preliminary study of a modified, nonflared, short, fully covered metal stent for refractory benign pancreatic duct strictures (with videos). Gastrointest Endosc. 2019. PMID: 31738924. doi:10.1016/j.gie.2019.11.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。